Further investigations found that heterogeneous signals in MRS analysis could possibly deliver information about the subtype of pituitary adenoma [60] and that the choline to creatine ratio may predict the rate of expression of SSTR2 and therefore give information about the effect of medical therapy [61]. This evidence concerns the gene SSTR2 and pituitary gland adenoma.